Healthcare provider profile · identity verified

Cassaundra Thompson

Family Practice · JACKSONVILLE, FL · NPI 1124569215

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	218	71
Amlodipine Besylate	Amlodipine Besylate	159	59
Lisinopril	Lisinopril	132	43
Losartan Potassium	Losartan Potassium	132	43
Levothyroxine Sodium	Levothyroxine Sodium	97	38
Metformin Hcl	Metformin Hcl	97	39
Hydrochlorothiazide	Hydrochlorothiazide	93	35
Rosuvastatin Calcium	Rosuvastatin Calcium	80	31
Albuterol Sulfate Hfa	Albuterol Sulfate	76	26
Metoprolol Succinate	Metoprolol Succinate	64	28
Omeprazole	Omeprazole	60	30
Ozempic	Semaglutide	60	15
Gabapentin	Gabapentin	59	25
Famotidine	Famotidine	53	19
Trazodone Hcl	Trazodone Hcl	46	16
Sertraline Hcl	Sertraline Hcl	45	14
Duloxetine Hcl	Duloxetine Hcl	41	15
Alendronate Sodium	Alendronate Sodium	40	15
Allopurinol	Allopurinol	40	11
Escitalopram Oxalate	Escitalopram Oxalate	40	16
Baclofen	Baclofen	39	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	39	13
Tamsulosin Hcl	Tamsulosin Hcl	37	12
Furosemide	Furosemide	34	16
Simvastatin	Simvastatin	34	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	11
Metformin Hcl Er	Metformin Hcl	32	16
Fluticasone Propionate	Fluticasone Propionate	30	19
Montelukast Sodium	Montelukast Sodium	30	14
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Glipizide	Glipizide	28	suppressed
Bupropion Xl	Bupropion Hcl	27	11
Carvedilol	Carvedilol	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	24	14
Celecoxib	Celecoxib	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	14
Mirtazapine	Mirtazapine	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	17
Synthroid	Levothyroxine Sodium	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	16
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Eliquis	Apixaban	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Azithromycin	Azithromycin	15	14
Fluconazole	Fluconazole	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Prednisone	Prednisone	14	13
Propranolol Hcl	Propranolol Hcl	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error